Inflation Rate Expected to Reach 6 in Second Quarter Forecasters Indicate Suze Orman Warns Americans Underestimate Critical Retirement Healthcare Cost Technology Poised to Transform Healthcare Through Sensors 3D Printing and Personalization Foreign Investors Rotate from Nifty Giants to Indias Small and Midcap Markets Amid Growth Opportunities Alibaba Unveils NextGeneration Zhenwu AI Chip and New Large Language Model Perpetua Resources Secures 29 Billion US ExportImport Bank Loan for Critical Minerals Project in Idaho IX Q1 2026 Earnings EPS Misses Estimates as Operational Headwinds Persist MDV Q1 2026 Earnings Industrial REIT Reports Deep Earnings Miss as Losses Sharply Exceed Estimates Voyager Therapeutics Inc VYGR Q1 2026 Earnings Narrowed Loss and Pipeline Progress Support Positive Market Reaction Astera Labs Inc ALAB Q1 2026 Earnings EPS Surpasses Estimates as Shares Climb NAT Q4 2025 Earnings Significant EPS Miss Sends Stock Lower Journey Medical Q1 2026 Earnings Narrow EPS Miss as Shares Slide 4 CoDiagnostics Inc CODX Surges Over 36 Approaching Critical Resistance Gladstone Land Preferred Stock LANDO Slips Testing Key Support Levels Sonoma Pharmaceuticals SNOA Edges Higher Testing Key Resistance at 113 IAE Inches Higher Modest Gains Amid Asia Pacific Dividend Focus Etsy ETSY Surges 465 as Buyers Defend Key Support Level Trainline Raises Guidance Again Signaling Strong Digital Travel Demand PureTech Health Q4 2024 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports Results Xunlei Limited XNET Surges Over 6 Testing Key Resistance at 617 Teradata TDC Sheds 147 Testing Support Zone as Sector Headwinds Persist Monopar Therapeutics MNPR Surges 3 as Biotech Momentum Builds Tests Key Resistance Digi International Inc DGII Surges Over 3 as Positive Momentum Builds Allstate ALL Pulls Back From Resistance as Insurance Sector Navigates Uncertainty Vicor Corporation VICR Surges Over 24 Testing Key Resistance After Powerful Rally MACOM Technology Solutions MTSI Faces Headwinds as Stock Dips Nearly 3 eXoZymes Inc EXOZ Climbs 313 as Biotech Stock Tests Key Resistance at 1074